Search

Search Constraints

You searched for: Author/Creator Nishimura, Yasumasa

Search Results

1. 288. ASSOCIATION BETWEEN ENDOGENOUS SUBTYPE CLASSIFICATION FOR ESOPHAGEAL SQUAMOUS CELL CARCINOMA AND OUTCOME OF CHEMORADIOTHERAPY. (24th September 2022)

4. A phase II study of concurrent chemoradiotherapy with 5-fluorouracil and mitomycin-C for squamous cell carcinoma of the anal canal (the JROSG 10–2 trial). (23rd October 2022)

5. A randomised phase II trial of S-1 plus cisplatin versus vinorelbine plus cisplatin with concurrent thoracic radiotherapy for unresectable, locally advanced non-small cell lung cancer: WJOG5008L. Issue 6 (11th September 2018)

6. ACT-8 A RANDOMIZED PHASE III STUDY OF HYPOFRACTIONATED RADIOTHERAPY COMBINED WITH TEMOZOLOMIDE IN ELDERLY PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA: JCOG1910 (AGEDGLIO-PIII). (3rd December 2022)

7. An end-to-end postal audit test to examine the coincidence between the imaging isocenter and treatment beam isocenter of the IGRT linac system for Japan Clinical Oncology Group (JCOG) clinical trials. (September 2018)

9. An overview of the medical-physics-related verification system for radiotherapy multicenter clinical trials by the Medical Physics Working Group in the Japan Clinical Oncology Group–Radiation Therapy Study Group. (29th September 2020)

10. An updating approach for knowledge‐based planning models to improve plan quality and variability in volumetric‐modulated arc therapy for prostate cancer. Issue 9 (2nd August 2021)